ESR1 and breast cancer: We developed ER-deprived MCF-7 cells and identified the expression level of miR-33a in MCF-7 breast cancer cells in ER activation by ER agonist (estradiol-17β) and in ER deprivation using anti-estrogens (ICI 182,780, Fulvestrant).